Cramer's Lightning Round - Raptor Is As Speculative As It Gets (9/9/13)

by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday September 9.

Bullish Calls:

Avanir (NASDAQ:AVNR): "I don't regard it as a roller coaster. I regard it as a great spec biotech. Near the end of the year, we might take some profits. These spec biotechs have been hot."

Fortress Investment (NYSE:FIG): "The assets are coming to the fore. I have been negative about it. I am beginning to think it is a decent buy. That is a new position for me."

Primerica (NYSE:PRI): "It is a great long-term play on the baby boomers. It is a great company. Here is the problem. It is middle income, but it has variable annuity and it has mutual funds, and I like that group right now."

HCI Group (NYSE:HCI): "I like the homeowners insurance business. You've got a winner here. A lot of people think they are late in the cycle, but they are inexpensive on a book value."

Bearish Calls:

Raptor Pharmaceuticals (NASDAQ:RPTP): "That is an early stage biotech. Please ring the register. That is as speculative as it gets."

DaVita Healthcare Partners (NYSE:DVA): "I'm worried about it. DVA has reimbursement issues. I'd like them to clarify this. I can't get my arms around the problem. I need to know more."

Nuverra Environmental Solutions (NES): "People think there is a lot of drilling. There is a lot of oil drilling. You need to see more fracking for natural gas for this ... You don't have a lot of drilling. I looked at the rig count. It wasn't that good. That is why the stock hasn't run. it has been a big disappointment."


Jim Cramer's Action Alerts PLUS: Trade right alongside a Wall Street pro! Start your 14-day FREE trial today.

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.